Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 156 Records) |
| Query Trace: Melanoma and IMPACT[original query] |
|---|
| Characterization of Single Nucleotide Variants of OPN3 Gene in Melanocytic Nevi and Melanoma. JID innovations : skin science from molecules to population health 2021 12 1 (1): 100006. Zhang Wei, Feng Jianglong, Zeng Wen, Zhou Zhixu, Wang Yu, Lu Honggua |
| Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma. Cancers 2021 11 13 (22): . Terai Mizue, Shimada Ayako, Chervoneva Inna, Hulse Liam, Danielson Meggie, Swensen Jeff, Orloff Marlana, Wedegaertner Philip B, Benovic Jeffrey L, Aplin Andrew E, Sato Taka |
| Clinical predictors of survival in real world practice in stage IV melanoma. Cancer reports (Hoboken, N.J.) 2022 9 e1691. Hu Hsien-Pang, Archer Christine, Yip Desmond, Peters Geoffr |
| Melanoma-specific survival before and after inclusion in a familial melanoma dermatologic surveillance program in CDKN2A mutation carriers and non-carriers. Journal of the European Academy of Dermatology and Venereology : JEADV 2022 9 37 (2): 284-292. Pissa Maria, Lapins Jan, Sköldmark Christina, Helgadottir Hild |
| Eight gene mutation-based polygenic hazard score as a potential predictor for immune checkpoint inhibitor therapy outcome in metastatic melanoma. Frontiers in molecular biosciences 2022 9 9 1001792. Zhao Liqin, Luo Ting, Jiang Jinling, Wu Junwei, Zhang Xiaow |
| Outcomes of stage IV melanoma in the era of immunotherapy: a National Cancer Database (NCDB) analysis from 2014 to 2016. Journal for immunotherapy of cancer 2022 8 10 (8): . Sussman Tamara A, Knackstedt Rebecca, Wei Wei, Funchain Pauline, Gastman Brian |
| Amelanotic/hypopigmented melanoma in a sibship with oculocutaneous albinism. The Journal of dermatology 2022 7 49 (11): 1183-1187. Maas Ellie J, Wallingford Courtney K, McGuire Jessica J, Rutjes Chantal, Smit Darren J, Betz-Stablein Brigid, Sturm Richard A, Soyer H Peter, McInerney-Leo Aideen |
| Clinical Impact of Immune Checkpoint Inhibitor (ICI) Response, DNA Damage Repair (DDR) Gene Mutations and Immune-Cell Infiltration in Metastatic Melanoma Subtypes. Medical sciences (Basel, Switzerland) 2022 6 10 (2): . Andrieu Charlotte, McNamee Niamh, Larkin Anne-Marie, Maguire Alanna, Menon Roopika, Mueller-Eisert Judith, Horgan Noel, Kennedy Susan, Gullo Giuseppe, Crown John, Walsh Nao |
| A Genomic Signature Reflecting Fibroblast Infiltration Into Gastric Cancer Is Associated With Prognosis and Treatment Outcomes of Immune Checkpoint Inhibitors. Frontiers in cell and developmental biology 2022 5 10 862294. Lu Yi, Li Dan, Cao Yixin, Ying Leqian, Tao Qing, Xiong Fen, Hu Zhangmin, Yang Yufei, Qiao Xuehan, Peng Chen, Zhu Dongqin, Wang Deqiang, Li Xiaoq |
| Identification and Validation of a Gene Signature for Lower-Grade Gliomas Based on Pyroptosis-Related Genes to Predict Survival and Response to Immune Checkpoint Inhibitors. Journal of healthcare engineering 2022 2022 8704127. Lai Guichuan, Li Kangjie, Deng Jielian, Liu Hui, Xie Biao, Zhong Xiao |
| Associations between TERT Promoter Mutations and Survival in Superficial Spreading and Nodular Melanomas in a Large Prospective Patient Cohort. The Journal of investigative dermatology 2022 4 142 (10): 2733-2743.e9. Chang Gregory A, Robinson Eric, Wiggins Jennifer M, Zhang Yilong, Tadepalli Jyothirmayee S, Schafer Christine N, Darvishian Farbod, Berman Russell S, Shapiro Richard, Shao Yongzhao, Osman Iman, Polsky Dav |
| HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade. Annals of oncology : official journal of the European Society for Medical Oncology 2022 3 33 (7): 728-738. Shao X M, Huang J, Niknafs N, Balan A, Cherry C, White J, Velculescu V E, Anagnostou V, Karchin |
| Systematic review and meta-analysis of genomic alterations in acral melanoma. Pigment cell & melanoma research 2022 3 35 (3): 369-386. Broit Natasa, Johansson Peter A, Rodgers Chloe B, Walpole Sebastian T, Hayward Nicholas K, Pritchard Antonia |
| Vaginal melanoma in Denmark from 1980 to 2018: A population-based study based on genetic profile and survival. Gynecologic oncology 2022 Feb . Yazdanfard Natacha Würtz, Mikkelsen Lauge Hjorth, Behrendt Nille, Fuglsang Katrine, Blaakær Jan, Hölmich Lisbet Rosenkrantz, Frøding Ligita Paskeviciute, Munch-Petersen Helga Fibiger, Heegaard Steff |
| Fibroblast growth factor receptor family mutations as a predictive biomarker for immune checkpoint inhibitors and its correlation with tumor immune microenvironment in melanoma. Frontiers in immunology 2022 11 13 1030969. Zhang Wengang, Xia Handai, Yang Rui, Zhang Yuqing, Zheng Qi, Shang Xiaoling, Liu Ni, Ma Xinchun, Wei Chenxi, Chen Hang, Mu Xin, Wang Xiuwen, Liu Yang |
| Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers. JNCI cancer spectrum 2022 10 6 (6): . Sargen Michael R, Helgadottir Hildur, Yang Xiaohong R, Harland Mark, Hatton Jessica N, Jones Kristine, Hicks Belynda D, Hutchinson Amy, Curry Michael, Tucker Margaret A, Goldstein Alisa M, Pfeiffer Ruth |
| Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study. The British journal of dermatology 2022 1 186 (6): 977-987. Wei Xiaoting, Wu Di, Chen Yu, Li Hang, Zhang Rui, Yao Hong, Chi Zhihong, Cui Chuanliang, Bai Xue, Mao Lili, Qi Zhonghui, Li Ke, Lan Shijie, Chen Lizhu, Guo Rui, Yao Xinyu, Lian Bin, Kong Yan, Dai Jie, Tang Bixia, Wang Xuan, Guo Jun, Si |
| Metformin is associated with improved clinical outcomes in patients with melanoma: a retrospective, multi-institutional study. Frontiers in oncology 2023 7 13 1075823. Ryan C Augustin, Ziyu Huang, Fei Ding, Shuyan Zhai, Jennifer McArdle, Anthony Santisi, Michael Davis, Cindy Sander, Diwakar Davar, John M Kirkwood, Greg M Delgoffe, Allison Betof Warner, Yana G Najj |
| Unveiling the interplay between mutational signatures and tumor microenvironment: a pan-cancer analysis. Frontiers in immunology 2023 6 14 1186357. Li-Zhi Luo, Sheng Li, Chen Wei, Jiao Ma, Li-Mei Qian, Yan-Xing Chen, Shi-Xiang Wang, Qi Zh |
| Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. European journal of cancer (Oxford, England : 1990) 2023 6 . Oliver John Kennedy, Michal Kicinski, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U Blank, Georgina V Long, Victoria G Atkinson, Stéphane Dalle, Andrew M Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J M van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C J van Akkooi, Caroline Robert, Alexander M M Eggermont, Paul Lorigan, Mario Manda |
| Whole genome sequencing across clinical trials identifies rare coding variants in GPR68 associated with chemotherapy-induced peripheral neuropathy. Genome medicine 2023 6 15 (1): 45. Zia Khan, Min Jung, Megan Crow, Rajat Mohindra, Vidya Maiya, Joshua S Kaminker, David H Hackos, G Scott Chandler, Mark I McCarthy, Tushar Bhanga |
| Contributions of replicative and translesion DNA polymerases to mutagenic bypass of canonical and atypical UV photoproducts. Nature communications 2023 5 14 (1): 2576. Brittany N Vandenberg, Marian F Laughery, Cameron Cordero, Dalton Plummer, Debra Mitchell, Jordan Kreyenhagen, Fatimah Albaqshi, Alexander J Brown, Piotr A Mieczkowski, John J Wyrick, Steven A Rober |
| Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors. Journal for immunotherapy of cancer 2023 5 11 (5): . Julia-Christina Stadler, Laura Keller, Christian Mess, Alexander T Bauer, Julian Koett, Glenn Geidel, Isabel Heidrich, Sabine Vidal-Y-Sy, Antje Andreas, Carlotta Stramaglia, Mark Sementsov, Wiebcke Haberstroh, Benjamin Deitert, Inka Lilott Hoehne, Robin Reschke, Thomas Haalck, Klaus Pantel, Christoffer Gebhardt, Stefan W Schneid |
| Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG. European journal of cancer (Oxford, England : 1990) 2023 5 188 140-151. Anne Zaremba, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Claudia Pföhler, Michael Weichenthal, Patrick Terheyden, Andrea Forschner, Ulrike Leiter, Jens Ulrich, Jochen Utikal, Julia Welzel, Martin Kaatz, Christoffer Gebhardt, Rudolf Herbst, Anca Sindrilaru, Edgar Dippel, Michael Sachse, Frank Meiss, Lucie Heinzerling, Sebastian Haferkamp, Carsten Weishaupt, Harald Löffler, Sophia Kreft, Klaus Griewank, Elisabeth Livingstone, Dirk Schadendorf, Selma Ugurel, Lisa Zimm |
| Integrating single-cell analysis and machine learning to create glycosylation-based gene signature for prognostic prediction of uveal melanoma. Frontiers in endocrinology 2023 4 14 1163046. Liu Jianlan, Zhang Pengpeng, Yang Fang, Jiang Keyu, Sun Shiyi, Xia Zhijia, Yao Gang, Tang Ji |
| Pervasiveness of HLA allele-specific expression loss across tumor types. Genome medicine 2023 2 15 (1): 8. Filip Ioan, Wang Anqi, Kravets Oleksandr, Orenbuch Rose, Zhao Junfei, Perea-Chamblee Tomin E, Manji Gulam A, López de Maturana Evangelina, Malats Núria, Olive Kenneth P, Rabadan Ra |
| Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
| The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . T Fulton-Ward, G Middlet |
| Impact of Posaconazole and Diltiazem on Pharmacokinetics of Encorafenib, a BRAF V600 Kinase Inhibitor for Melanoma and Colorectal Cancer with BRAF Mutations. Clinical and translational science 2023 10 . Erik Hahn, Renae Chavira, Lance Wollenberg, Weiwei Tan, Micaela B Red |
| A new ferroptosis-related genetic mutation risk model predicts the prognosis of skin cutaneous melanoma. Frontiers in genetics 2023 1 13 988909. He Jia, Huang Wenting, Li Xinxin, Wang Jingru, Nie Yaxing, Li Guiqiang, Wang Xiaoxiang, Cao Huili, Chen Xiaodong, Wang Xushe |
- Page last reviewed:Oct 1, 2023
- Page last updated:Nov 28, 2023
- Content source: